Skip to main content
Top
Published in: BMC Health Services Research 1/2001

Open Access 01-12-2001 | Research article

Impact of patient characteristics on the risk of influenza/ILI-related complications

Authors: Debra E Irwin, Lisa B Weatherby, Wen-Yi Huang, Daniel M Rosenberg, Suzanne F Cook, Alexander M Walker

Published in: BMC Health Services Research | Issue 1/2001

Login to get access

Abstract

Background

We sought to quantify the impact of patient characteristics on complications and health care costs associated with influenza and influenza-like illness (ILI) in a nonelderly population.

Methods

Patients with medical reimbursement claims for influenza in the 1996–1997 season were identified from the automated database of a large private New England Insurer (NEI). Influenza care during the 21- day follow-up period was characterized according to age, gender, vaccine status, co-morbidities, prior influenza/ILI episodes, treatments, and recent health care costs and related diagnoses.

Results

There were 6,241 patients. Approximately 20% had preexisting chronic lung disease. Overall, 23% had health care services for possible complications, among which respiratory diagnoses were the most common (13%). Two percent of the influenza/ILI episodes involved hospitalization, with a median stay of five days. Factors most strongly predictive of hospitalizations and complications were preexisting malignancy (hospitalizations OR = 3.7 and complications OR = 2.4), chronic heart disease (OR = 3.2 and OR = 1.8), diabetes (OR = 2.2 and OR = 1.7) and recent illnesses that would have counted as complications had they occurred during an influenza/ILI episode (hospitalizations OR = 3.2 and complications OR = 1.5). The same factors affected influenza-related costs and total costs of care as dramatically as they affected complication rates.

Conclusions

Influenza/ILI-related costs are driven by the characteristics that predict complications of influenza. Patients with chronic illness and those with recent acute respiratory events are the most likely to experience complications and hospitalizations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Simonsen L, Clarke MJ, Williamson GD, Stroup D, Arden NH, Schonberger LB: The Impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997, 87: 1944-1950.CrossRefPubMedPubMedCentral Simonsen L, Clarke MJ, Williamson GD, Stroup D, Arden NH, Schonberger LB: The Impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997, 87: 1944-1950.CrossRefPubMedPubMedCentral
2.
go back to reference Barker WH: Excess pneumonia and influenza-associated hospitalization during influenza epidemics in the U.S., 1970–1978. Am J Public Health. 1986, 76: 761-765.CrossRefPubMedPubMedCentral Barker WH: Excess pneumonia and influenza-associated hospitalization during influenza epidemics in the U.S., 1970–1978. Am J Public Health. 1986, 76: 761-765.CrossRefPubMedPubMedCentral
3.
go back to reference Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000, 49(No. RR-3). Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000, 49(No. RR-3).
4.
go back to reference Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1998, 47(RR-6): 1-26. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1998, 47(RR-6): 1-26.
5.
go back to reference Perotta DM, Decker M, Glezen WP: Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza:. Am J Epidemiol. 1985, 122: 468-476. Perotta DM, Decker M, Glezen WP: Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza:. Am J Epidemiol. 1985, 122: 468-476.
6.
go back to reference Nichol K: Complications of influenza and benefits of vaccination. Vaccine. 1999, 17: S47-S52. 10.1016/S0264-410X(99)00309-6.CrossRefPubMed Nichol K: Complications of influenza and benefits of vaccination. Vaccine. 1999, 17: S47-S52. 10.1016/S0264-410X(99)00309-6.CrossRefPubMed
7.
go back to reference McBean A, Babish J, Warren J: The impact and cost of influenza in the elderly. Arch Intern Med. 1993, 153: 2105-2111. 10.1001/archinte.153.18.2105.CrossRefPubMed McBean A, Babish J, Warren J: The impact and cost of influenza in the elderly. Arch Intern Med. 1993, 153: 2105-2111. 10.1001/archinte.153.18.2105.CrossRefPubMed
8.
go back to reference International Classification of Diseases, 9th Revision, Clinical Modification. 5th edition. Medicode Publications, Salt Lake City UT,. 1997 International Classification of Diseases, 9th Revision, Clinical Modification. 5th edition. Medicode Publications, Salt Lake City UT,. 1997
9.
go back to reference American Medical Association: Physicians' Current Procedural Terminology: CPT 97. American Medical Association, Chicago IL,. 1997 American Medical Association: Physicians' Current Procedural Terminology: CPT 97. American Medical Association, Chicago IL,. 1997
10.
go back to reference HCPCS: Medicare's National Level II Codes. Medicode Publications, Salt Lake City UT,. 1997 HCPCS: Medicare's National Level II Codes. Medicode Publications, Salt Lake City UT,. 1997
11.
go back to reference AHFS 97: Drug Information. American Hospital Formulary Service, Bethesda MD,. 1997 AHFS 97: Drug Information. American Hospital Formulary Service, Bethesda MD,. 1997
12.
go back to reference The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group: Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 1998, 352: 1877-81. 10.1016/S0140-6736(98)10190-3.CrossRef The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group: Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 1998, 352: 1877-81. 10.1016/S0140-6736(98)10190-3.CrossRef
13.
go back to reference Mullooly J, Bennett M, Hornbrook M, Barker W, Williams W, Patriarca P, Rhodes P: Influenza vaccination programs for elderly persons: cost effectiveness in a health maintenance organization. Ann Intern Med. 1994, 121: 947-952.CrossRefPubMed Mullooly J, Bennett M, Hornbrook M, Barker W, Williams W, Patriarca P, Rhodes P: Influenza vaccination programs for elderly persons: cost effectiveness in a health maintenance organization. Ann Intern Med. 1994, 121: 947-952.CrossRefPubMed
14.
go back to reference Nichol K: Complications of influenza and benefits of vaccination. Vaccine. 1999, 17: S47-S52. 10.1016/S0264-410X(99)00309-6.CrossRefPubMed Nichol K: Complications of influenza and benefits of vaccination. Vaccine. 1999, 17: S47-S52. 10.1016/S0264-410X(99)00309-6.CrossRefPubMed
15.
go back to reference Postma M, Bos J, van Gennep M, Jager J, Baltussen R, Sprenger M: Economic evaluation of influenza vaccination. Assessment for the Netherlands. Pharmacoeconomics. 1999, 16 Suppl 1: 33-40.CrossRefPubMed Postma M, Bos J, van Gennep M, Jager J, Baltussen R, Sprenger M: Economic evaluation of influenza vaccination. Assessment for the Netherlands. Pharmacoeconomics. 1999, 16 Suppl 1: 33-40.CrossRefPubMed
16.
go back to reference Nichol K, Margolis K, Wuorenma J, Von Sternberg T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. NEJM. 1994, 331: 778-784. 10.1056/NEJM199409223311206.CrossRefPubMed Nichol K, Margolis K, Wuorenma J, Von Sternberg T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. NEJM. 1994, 331: 778-784. 10.1056/NEJM199409223311206.CrossRefPubMed
17.
go back to reference World Health Organization. Weekly Epidemiology Record. 1998, 73(7): 41-48. World Health Organization. Weekly Epidemiology Record. 1998, 73(7): 41-48.
18.
go back to reference Centers for Disease Control and Prevention: Surveillance for Influenza – United States, 1994–95, 1995–96, and 1996–97 Seasons. MMWR. 2000, 49(SS03): 13-28. Centers for Disease Control and Prevention: Surveillance for Influenza – United States, 1994–95, 1995–96, and 1996–97 Seasons. MMWR. 2000, 49(SS03): 13-28.
19.
go back to reference Mandell G, Bennett J, Dolin R: Principles and Practice of Infectious Disease. 4th Edition, Churchill Livingstone. 1995 Mandell G, Bennett J, Dolin R: Principles and Practice of Infectious Disease. 4th Edition, Churchill Livingstone. 1995
Metadata
Title
Impact of patient characteristics on the risk of influenza/ILI-related complications
Authors
Debra E Irwin
Lisa B Weatherby
Wen-Yi Huang
Daniel M Rosenberg
Suzanne F Cook
Alexander M Walker
Publication date
01-12-2001
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2001
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-1-8

Other articles of this Issue 1/2001

BMC Health Services Research 1/2001 Go to the issue